Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 60

1.

Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data.

Wallace BC, Schmid CH, Lau J, Trikalinos TA.

BMC Med Res Methodol. 2009 Dec 4;9:80. doi: 10.1186/1471-2288-9-80.

2.

Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality.

Pocobelli G, Peters U, Kristal AR, White E.

Am J Epidemiol. 2009 Aug 15;170(4):472-83. doi: 10.1093/aje/kwp167.

3.

Forty years of secondhand smoke research: the gap between discovery and delivery.

Harris JK, Luke DA, Zuckerman RB, Shelton SC.

Am J Prev Med. 2009 Jun;36(6):538-48. doi: 10.1016/j.amepre.2009.01.039.

PMID:
19372026
4.

Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role?

Dietrich M, Jacques PF, Pencina MJ, Lanier K, Keyes MJ, Kaur G, Wolf PA, D'Agostino RB, Vasan RS.

Atherosclerosis. 2009 Aug;205(2):549-53. doi: 10.1016/j.atherosclerosis.2008.12.019.

5.

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.

Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM.

JAMA. 2008 Nov 12;300(18):2123-33. doi: 10.1001/jama.2008.600.

6.

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators..

Lancet. 2008 Oct 4;372(9645):1223-30. doi: 10.1016/S0140-6736(08)61239-8.

PMID:
18757090
7.

Nutrition and disease in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC).

Iso H, Kubota Y; Japan Collaborative Cohort Study for Evaluation of Cancer..

Asian Pac J Cancer Prev. 2007;8 Suppl:35-80.

8.
9.

Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.

Milman U, Blum S, Shapira C, Aronson D, Miller-Lotan R, Anbinder Y, Alshiek J, Bennett L, Kostenko M, Landau M, Keidar S, Levy Y, Khemlin A, Radan A, Levy AP.

Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):341-7.

10.
11.

Frequency of fish consumption, retinal microvascular signs and vascular mortality.

Kaushik S, Wang JJ, Flood V, Liew G, Smith W, Mitchell P.

Microcirculation. 2008 Jan;15(1):27-36.

PMID:
17907016
12.

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study.

Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE.

Arch Intern Med. 2007 Aug 13-27;167(15):1610-8.

14.

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators..

Lancet. 2007 Mar 31;369(9567):1090-8. Erratum in: Lancet. 2007 Jul 21;370(9583):220.

PMID:
17398308
15.

Depression and cardiovascular mortality: a role for n-3 fatty acids?

Kamphuis MH, Geerlings MI, Tijhuis MA, Kalmijn S, Grobbee DE, Kromhout D.

Am J Clin Nutr. 2006 Dec;84(6):1513-7.

16.

Fish intake, contaminants, and human health: evaluating the risks and the benefits.

Mozaffarian D, Rimm EB.

JAMA. 2006 Oct 18;296(15):1885-99. Review. Erratum in: JAMA. 2007 Feb 14;297(6):590.

PMID:
17047219
17.

Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial.

Brouwer IA, Zock PL, Camm AJ, Böcker D, Hauer RN, Wever EF, Dullemeijer C, Ronden JE, Katan MB, Lubinski A, Buschler H, Schouten EG; SOFA Study Group..

JAMA. 2006 Jun 14;295(22):2613-9.

PMID:
16772624
18.

Intake of fish and long-chain n-3 fatty acids and the risk of coronary heart mortality in men and women.

Järvinen R, Knekt P, Rissanen H, Reunanen A.

Br J Nutr. 2006 Apr;95(4):824-9.

PMID:
16571163
19.

Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial.

Marchioli R, Levantesi G, Macchia A, Maggioni AP, Marfisi RM, Silletta MG, Tavazzi L, Tognoni G, Valagussa F; GISSI-Prevenzione Investigators..

J Membr Biol. 2005 Jul;206(2):117-28.

PMID:
16456722
20.

Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I.

Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, Kokubo Y, Tsugane S; JPHC Study Group..

Circulation. 2006 Jan 17;113(2):195-202.

Supplemental Content

Support Center